- Chair, Department of Radiology, UH Cleveland Medical Center
- Co-Director, Diagnostic Institute, UH Cleveland Medical Center
- Professor of Radiology, CWRU School of Medicine
- Professor of Pathology, CWRU School of Medicine
Donna M. Plecha, MD, is a nationally known expert in breast imaging who has received awards and honors for excellence in education and leadership including Top Doctors in America, Best Doctors in Cleveland, Castle Connolly Top Doctor and Department of Radiology Teacher of the Year Award. Dr. Plecha is a member of numerous professional societies including the Society of Breast Imaging, American College of Radiology, and the American Roentgen Ray Society. Dr. Plecha was instrumental in bringing Digital Breast Tomosynthesis (3-D Mammography) to Northeast Ohio.
She is Division Chief of Breast Imaging at University Hospitals Cleveland Medical Center and Chair and Professor of Diagnostic Radiology at Case Western Reserve University School of Medicine. She has authored many peer-reviewed publications, including a recent article in Journal of American Medical Association on the efficacy of 3-D mammography on improving breast cancer screening. In addition, she has been invited to lecture nationally, internationally, and has been interviewed on local and national news programs.
Dr. Plecha received her M.D. from Case Western Reserve University School of Medicine and completed her residency and fellowship in Breast Imaging in the Department of Radiology, University Hospitals Cleveland Medical Center.
- Breast Cancer
- Breast Imaging
- Diagnostic Radiology
Certifications & Memberships
- Diagnostic Radiology - American Board of Radiology
Fellowship | Breast Imaging
Breast Imaging - University Hospitals Of Cleveland (1992 - 1993)
Residency | Diagnostic Radiology
Diagnostic Radiology - University Hospitals Of Cleveland (1989 - 1992)
Internship | Rotator
Rotator - University Hospitals Of Cleveland (1988 - 1989)
Case Western Reserve University School Of Medicine (1988)
Northwestern University (1984)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Donna Plecha did not disclose any Outside Relationships with Industry.